Mechanisms of Action of Phytochemicals from Medicinal Herbs in the Treatment of Alzheimer's Disease

被引:74
|
作者
Kim, Mi Hye [1 ,2 ]
Kim, Sung-Hoon [3 ]
Yang, Woong Mo [1 ,2 ]
机构
[1] Kyung Hee Univ, Coll Korean Med, Seoul 130701, South Korea
[2] Kyung Hee Univ, Inst Korean Med, Seoul 130701, South Korea
[3] Kyung Hee Univ, Coll Korean Med, Canc Prevent Mat Dev Res Ctr, Seoul 130701, South Korea
基金
新加坡国家研究基金会;
关键词
Alzheimer's disease; phytochemical; medicinal herbs; drug development; AMYLOID PRECURSOR PROTEIN; NF-KAPPA-B; GINSENOSIDE RG1; BETA-SECRETASE; A-BETA; COGNITIVE IMPAIRMENT; IN-VITRO; INFLAMMATORY RESPONSE; CURCUMIN PROTECTS; OXIDATIVE STRESS;
D O I
10.1055/s-0034-1383038
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Alzheimer's disease is a chronic neurodegenerative disorder characterized by progressive dementia and deterioration of cognitive function. Although several drugs currently used for the treatment of Alzheimer's disease delay its onset and slow its progression, still there is no drug with profound disease-modifying effects. Studies aiming the treatment of this neurodegenerative disorder explore various disease mechanisms. Since antiquity, medicinal herbs have been used in traditional medicine. Recent studies suggest that the neurobiological effects of phytochemicals from medicinal herbs may contribute to clinical benefits in in vitro and in vivo models of Alzheimer's disease. This review focuses on five phytochemicals, berberine, curcumin, ginsenoside Rg1, puerarin, and silibinin, which have been mostly investigated to treat the development and progression of this neurodegenerative disorder.
引用
收藏
页码:1249 / 1258
页数:10
相关论文
共 50 条
  • [31] Wilson's disease: Treatment on integrated traditional Chinese medicinal herbs and western medicine
    Wang, X. -P.
    Li, W.
    Wang, J. -F.
    MOVEMENT DISORDERS, 2011, 26 : S347 - S348
  • [32] Ginkgolides and bilobalide for treatment of Alzheimer's disease and COVID-19: potential mechanisms of action
    Niu, T. -T.
    Yuan, B. -Y.
    Liu, G. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (24) : 9502 - 9510
  • [33] From mechanisms to drugs in Alzheimer's disease
    Fricker, J
    LANCET, 1997, 349 (9050): : 480 - 480
  • [34] Depression in Alzheimer's Disease: Epidemiology, Mechanisms, and Treatment
    Huang, Yu-Yuan
    Gan, Yi-Han
    Yang, Liu
    Cheng, Wei
    Yu, Jin-Tai
    BIOLOGICAL PSYCHIATRY, 2024, 95 (11) : 992 - 1005
  • [35] Ginkgo biloba extract:: From molecular mechanisms to the treatment of Alzheimer's disease
    Zimmermann, M
    Colciaghi, F
    Cattabeni, F
    Di Luca, M
    CELLULAR AND MOLECULAR BIOLOGY, 2002, 48 (06) : 613 - 623
  • [36] Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy
    Perry, EK
    Pickering, AT
    Wang, WW
    Houghton, PJ
    Perry, NSL
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (05) : 527 - 534
  • [37] Medicinal herbs and antioxidants: potential of Rhinacanthus nasutus for disease treatment?
    Brimson, James M.
    Tencomnao, Tewin
    PHYTOCHEMISTRY REVIEWS, 2014, 13 (03) : 643 - 651
  • [38] Medicinal herbs and antioxidants: potential of Rhinacanthus nasutus for disease treatment?
    James M. Brimson
    Tewin Tencomnao
    Phytochemistry Reviews, 2014, 13 : 643 - 651
  • [39] Multi-Targeting Phytochemicals for Alzheimer's Disease
    Bhattacharya, Radha Shree
    Singh, Raghuraj
    Panghal, Archna
    Thakur, Ashima
    Singh, Lachhman
    Verma, Rahul Kumar
    Singh, Charan
    Goyal, Manoj
    Kumar, Jayant
    PHYTOTHERAPY RESEARCH, 2025, 39 (03) : 1453 - 1483
  • [40] Naturally occurring phytochemicals for the prevention of Alzheimer's disease
    Kim, Jiyoung
    Lee, Hyong Joo
    Lee, Ki Won
    JOURNAL OF NEUROCHEMISTRY, 2010, 112 (06) : 1415 - 1430